🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate the efficacy of ranibizumab in combination with reduced-flue...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01968486
Treatments Being Tested
In this pilot study the researchers will evaluate the safety and efficacy o...
Status
Completed
Location
Eagle Mountain Vision
Start Date
2007-05
Trial ID
NCT00473642
Treatments Being Tested
Study the effectiveness of the treatment detachment of retinal pigment epit...
Status
Withdrawn
Location
Universidade Federal de São Paulo - Escola Paulista de Medicina
Start Date
2012-09
Trial ID
NCT01666236
Treatments Being Tested
This study will investigate the safety and efficacy of treatment of choroid...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT01025063
The purposes of this study is to determine if combination reduced fluence p...
Status
Withdrawn
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00726973
Treatments Being Tested
This study evaluated the effect of combination therapy with verteporfin pho...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-02
Trial ID
NCT00436553
Treatments Being Tested
The objective of this study is to determine if combination therapy (reduced...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00492284
Treatments Being Tested
The PDT/Lucentis trial will be a Phase IV comparative trial comparing the u...
Status
Terminated
Location
Vitreoretinal Consultants
Start Date
2007-01
Trial ID
NCT00423189
Treatments Being Tested
The purpose of this study is to determine the benefits, if any, of combinat...
Status
Unknown
Location
Barnes Retina Institute
Start Date
2007-04
Trial ID
NCT00455871
Treatments Being Tested
Single agent anti-VEGF therapies such as ranibizumab have shown great promi...
Status
Completed
Location
California Retina Consultants & Research Foundation
Start Date
2007-05
Trial ID
NCT00527475
Treatments Being Tested